Basal Cell Carcinoma (BCC) Completed Phase 4 Trials for Vismodegib (DB08828)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

IndicationStatusPhase
DBCOND0040396 (Basal Cell Carcinoma (BCC))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02436408VISmodegib for ORbital and Periocular Basal Cell CarcinomaTreatment